T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 15.17% |
| 4 | Financials | 10.75% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CINC
1326
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $12.6M | ﹤0.01% |
+718,875
| New | +$14.8M |
|
1327
Hagerty
HGTY
$1.31B
| $12.4M | ﹤0.01% |
1,151,575
-848,425
| -42% | -$12.1M |
|
1328
Invitation Homes
INVH
$18.1B
| $12.4M | ﹤0.01% |
309,168
+21,361
| +7% | +$874K |
|
|
SWCH
1329
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $12.4M | ﹤0.01% |
401,721
+388,378
| +2,911% | +$10.4M |
|
1330
iShares Core MSCI EAFE ETF
IEFA
$196B
| $12.3M | ﹤0.01% |
177,402
-243,941
| -58% | -$17.3M |
|
1331
iShares Russell 1000 Growth ETF
IWF
$128B
| $12.3M | ﹤0.01% |
176,944
-192,440
| -52% | -$13.1M |
|
|
VMW
1332
DELISTED
VMware, Inc
VMW
| $12.3M | ﹤0.01% |
107,581
+5,552
| +5% | +$673K |
|
1333
Lamb Weston
LW
$7.36B
| $12.1M | ﹤0.01% |
202,554
-13,031
| -6% | -$810K |
|
|
PBCT
1334
DELISTED
People's United Financial Inc
PBCT
| $12M | ﹤0.01% |
600,650
-38,694
| -6% | -$790K |
|
1335
Pentair
PNR
$10.5B
| $11.9M | ﹤0.01% |
219,325
-10,589
| -5% | -$641K |
|
1336
iShares Core S&P 500 ETF
IVV
$909B
| $11.9M | ﹤0.01% |
26,197
-22,841
| -47% | -$10.2M |
|
|
ZEN
1337
DELISTED
ZENDESK INC
ZEN
| $11.8M | ﹤0.01% |
98,476
-4,384
| -4% | -$476K |
|
1338
Marqeta
MQ
$1.71B
| $11.7M | ﹤0.01% |
265,715
-465,085
| -64% | -$21.6M |
|
1339
Vir Biotechnology
VIR
$1.54B
| $11.6M | ﹤0.01% |
450,363
-147,070
| -25% | -$4.36M |
|
1340
Badger Meter
BMI
$3.8B
| $11.6M | ﹤0.01% |
116,018
+65,695
| +131% | +$6.44M |
|
1341
Palantir
PLTR
$425B
| $11.5M | ﹤0.01% |
839,566
+62,828
| +8% | +$838K |
|
1342
Newell Brands
NWL
$2.63B
| $11.5M | ﹤0.01% |
536,289
-43,999
| -8% | -$1.02M |
|
1343
Sprott Physical Gold and Silver Trust
CEF
$8.23B
| $11.2M | ﹤0.01% |
578,760
-137,117
| -19% | -$2.53M |
|
1344
DXC Technology
DXC
$1.73B
| $11.2M | ﹤0.01% |
341,996
-22,523
| -6% | -$745K |
|
1345
Plug Power
PLUG
$3.26B
| $11.1M | ﹤0.01% |
388,628
+14,957
| +4% | +$356K |
|
1346
Markel Group
MKL
$22.8B
| $11M | ﹤0.01% |
7,438
+229
| +3% | +$296K |
|
|
DISCK
1347
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $10.9M | ﹤0.01% |
436,858
-51,310
| -11% | -$1.39M |
|
1348
Genpact
G
$5.71B
| $10.7M | ﹤0.01% |
245,038
+7,431
| +3% | +$344K |
|
1349
ThredUp
TDUP
$407M
| $10.6M | ﹤0.01% |
1,379,796
-1,249,872
| -48% | -$10.9M |
|
1350
United Therapeutics
UTHR
$21.4B
| $10.6M | ﹤0.01% |
58,861
+143
| +0.2% | +$27.2K |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.